The weekly litigation news digest is live. Subscribe now

Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist

Patent No. EP2228064 (titled "Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist") was filed by Novartis on May 17, 2005. The application was issued on Dec 11, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2228064

NOVARTIS
Application Number
EP10164976A
Filing Date
May 17, 2005
Status
Granted And Under Opposition
Nov 8, 2019
Publication Date
Dec 11, 2019